MOUNT PLEASANT, S.C.--(BUSINESS WIRE)--Revolutions Medical Corporation (OTCBB: RMCP) is filing for International patent protection in Mexico, Canada, China, Japan, and Europe for its additional RevVac Syringe patent. “It is very important to have foreign protection for our proprietary safety syringe technology as we move through the FDA 510K application process and into manufacturing,” states Ron Wheet, CEO of Revolutions Medical Corporation. Richard Moseley, United States Patent Attorney said, “I have been writing syringe patents for more than twenty years and Revolutions Medical’s proprietary vacuum technology patents are the most unique and advanced for the safety syringe market that I have ever read or worked on.”
